Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through

Lee W Slice1, Terence Chiu, Enrique Rozengurt

  • 1Department of Medicine, David Geffen School of Medicine at UCLA, the CURE: Digestive Diseases Research Center, the Jonnson Comprehensive Cancer Center, University of California, Los Angeles 90095-1786, USA. lslice@mednet.ucla.edu

Insights

Angiotensin II (Ang II) and epidermal growth factor (EGF) stimulate cyclooxygenase-2 (COX-2) expression in intestinal cells via distinct signaling pathways. Ang II uses p38MAPK and Ca2+ signaling, while EGF relies on ERK, both involving small GTPases.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Gastroenterology

Background:

  • Colorectal carcinogenesis involves genetic mutations and altered signaling pathways controlling cell proliferation, differentiation, and apoptosis.
  • Cyclooxygenase-2 (COX-2) is upregulated in colorectal tumors, promoting proliferation, inhibiting apoptosis, and increasing invasiveness.
  • Regulation of COX-2 expression by endogenous cell-surface receptors is not fully understood.

Purpose of the Study:

  • To investigate the signaling mechanisms by which angiotensin II (Ang II) and epidermal growth factor (EGF) regulate cyclooxygenase-2 (COX-2) expression in intestinal epithelial cells.
  • To elucidate the roles of small GTPases, MAP kinases, and calcium signaling in Ang II- and EGF-induced COX-2 expression.

Main Methods:

  • Used a rat intestinal epithelial cell line (IEC-18).
  • Stimulated cells with Ang II and EGF, then measured COX-2 mRNA and protein expression.
  • Employed inhibitors for specific signaling pathways (small GTPases, ERK, p38MAPK, Ca2+ signaling) and performed luciferase promoter assays.

Main Results:

  • Ang II potently stimulated COX-2 expression via the Ang II type 1 receptor, increasing prostaglandin I2 production.
  • EGF also induced COX-2 expression.
  • Ang II-induced COX-2 expression involved Cdc42 activation, p38MAPK, and Ca2+ mobilization.
  • EGF-induced COX-2 expression involved Rac activation and ERK activation.
  • Inhibition of small GTPases blocked COX-2 induction by both Ang II and EGF.
  • Specific inhibitors differentiated the signaling pathways: p38MAPK and Ca2+ for Ang II; ERK for EGF.

Conclusions:

  • Ang II and EGF differentially regulate COX-2 expression in intestinal epithelial cells through distinct signaling cascades.
  • Ang II-dependent COX-2 induction relies on small GTPases, p38MAPK, and Ca2+ signaling.
  • EGF-dependent COX-2 induction involves small GTPases and ERK signaling.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...